Showing results (121-130 of 140) with videos related to
Sort By:
Pageof 14
Cell|August 27, 2025
Human monoclonal antibodies targeting A35 protect from death caused by mpoxRaianna F Fantin, Meng Yuan, Seok-Chan Park, et al.Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 7, 2026
Myeloid-avid mTOR-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantationKatsutaka Mineura, Charles R Liu, Junedh M Amrute, et al.Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.Med (New York, N.Y.)|August 31, 2022
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariantsJ Andrew Duty, Thomas Kraus, Heyue Zhou, et al.Nature|September 13, 2021
Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Yong Yu, Jakob Trimpert, et al.Nature|July 25, 2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Shuofeng Yuan, Xin Yin, et al.Immunity|February 10, 2026
Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heartJeffrey Downey, Ana Oliveira-Coelho, Máté G Kiss, et al.Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.Pageof 14